Cargando…
Telomerase-Targeted Cancer Immunotherapy
Telomerase, an enzyme responsible for the synthesis of telomeres, is activated in many cancer cells and is involved in the maintenance of telomeres. The activity of telomerase allows cancer cells to replicate and proliferate in an uncontrolled manner, to infiltrate tissue, and to metastasize to dist...
Autores principales: | Mizukoshi, Eishiro, Kaneko, Shuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515163/ https://www.ncbi.nlm.nih.gov/pubmed/31013796 http://dx.doi.org/10.3390/ijms20081823 |
Ejemplares similares
-
Immune cell therapy for hepatocellular carcinoma
por: Mizukoshi, Eishiro, et al.
Publicado: (2019) -
Anti-Cancer Immunotherapies Targeting Telomerase
por: Negrini, Simone, et al.
Publicado: (2020) -
Comprehensive and efficient analyses of T cell receptors for cancer antigens in peptide-vaccinated patients using a single cell-based gene cloning system
por: Nakagawa, Hidetoshi, et al.
Publicado: (2014) -
Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Protocol for a Safety Study
por: Nomura, Akihiro, et al.
Publicado: (2020) -
Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma
por: Iida, Noriho, et al.
Publicado: (2019)